Amplify files for a sports ETF with a 15% private sleeve
The index supplies the story and the daily price; the franchise stakes supply the differentiation nobody can quote.
Story archive
All ETF Daily reporting, newest first.
Options ETFs hit $300 billion with half the room still undecided
A decade of listings built a $300 billion options category, but buyers cannot agree what they own, and the next leg turns on a shared language rather than more launches.
NTHM's rebalance sold SaaS and batteries for obesity drugs and pipelines
The rotation index does the selling for you, which is why its GLP-1 weight says nothing about obesity-drug economics and a lot about what was moving when the screen ran.
Midstream's $1.1 billion is an income bid
AMLP and ENFR took the category's money while trailing the broader energy sector by more than 17 points, which tells you what buyers are actually paying for.
Options ETFs hit $300 billion with half the room undecided
A decade of listings built a $300 billion options category. Half the room has not bought, and the buyers who have cannot agree on what they own, so the next leg turns on explanation.
AllianceBernstein hands its ETF suite to an internal builder
AB's $16 billion ETF business is growing faster than the rest of the firm and still amounts to about 2 percent of it.
The ETF shelf is rented, and issuers keep paying
Fee cuts and acquisitions are the same trade — buying access — and this week's numbers show distribution, not performance, sets the price.
Texas takes a listing. Keeping it traded is harder.
The SEC's 60/75-day effectiveness window once set the launch calendar; with four funds listed on TXSE, the gatekeeper is whoever agrees to quote them.
TURF's 35.7% is a two-name energy trade wearing an active fee
A natural-resources fund whose write-up credits Exxon and Shell has to prove the 44 basis points are buying selection, not a leveraged bet on the commodities underneath it.
Fixed-income flows are parked at the front end, not the long end
The conference-stage debate over long bonds and derivative income is a bet on when the front-end parking trade unwinds, and the $459 billion record gives the timeline.
Texas Stock Exchange's first ETF slate is the easy test
TXSE has proved it can take a listing. Whether it can keep one liquid is the question none of its first four funds answers.
The multi-factor comeback is a hedge against the index
Five billion dollars has flowed into multi-factor ETFs this year as insurance against the index itself, and RAFI's own weights show what the policy actually covers.
NTHM's Rulebook Cut Tech and Bought Pipelines. The Product Is the Rulebook.
One rebalance took technology from 40.78% to 25.20% and handed the energy and healthcare sleeves to pipelines and GLP-1 makers, the wrapper working exactly as designed.
American Century renames a three-year winner and cuts its fee anyway
The rename widens the buyer list, while the fee cut suggests the firm would rather buy shelf space than argue its record.
FLDB's 3.9% year is a curve trade, not a track record
The 20-basis-point fund's edge over the Agg comes mainly from where it sits on the curve, and its three-year shelf moment will be judged against whatever the front end is paying then.
The Fed hiked, and the front-end parking trade got fuller
A record $459 billion year for fixed income ETFs is running through the front end, and the first hike since 2023 is what keeps it there.
QVML is a cheap S&P 500 tilt wearing an all-weather label
A multi-factor fund that moves with the index at 0.97 is a defensible fee trade. The all-weather label promises protection the correlation never supplied.
TTEQ's 22-point lead is the wrapper earning its fee
T. Rowe Price's active tech ETF has the returns; the question is whether a mandate built on a definition index funds cannot use holds up when technology leadership narrows.
REX's CHIP fund buys the bottleneck after the index ran 126.6%
The fund opened with 52.5% in ten names and a third of its assets in one country, leaving the first-year return to the rebalance calendar as much as the theme.
REX's CHIP fund buys the bottleneck after the index ran 126.6%
A concentrated bet on the toolmakers puts 52.5% in ten names and a third of the fund in one country, leaving the first-year return to the rebalance calendar as much as the theme.
August's ETF flows went to three promoters and one country
Three promoters took half of August's $245.8 billion ETF inflows, the US took three-quarters, and the one fixed-income line near the top is a short-duration parking trade.
The ETF shelf is rented now
Three Tidal trusts took 13 of the week's 25 listings, and the filing record shows the platform model doing the rest of the work.
The staples-discretionary spread is a holding-level story
State Street fund data shows a handful of names carrying this year's 13.61-point sector gap.
The muni ETF leaderboard is a fee ranking in disguise
Three active muni funds top ETF Trends' screen with three-year returns of 4.44% to 4.75%, and the nine-basis-point spread in their fees is doing the ranking.
Three August ETF deals price a book of advisor relationships
August's three ETF acquisitions priced the scarce asset—a book of advisor relationships—and the next wave will be issuers who own one and cannot sell it.
Rulebooks are selling AI while private capital buys it
HALX, QGRO, VFLO and OUSM rotated out of AI exposure their holders never voted to sell; Brookfield and Google kept underwriting the buildout instead.
ELFY's new top holding is a rounding error with a crown
Twelve basis points separate first from second in a 112-name index, and the rebalance tells investors which side of the electrification trade the fund now wants to own.
The ETF wrapper that turns private credit into listed-fund beta
PCR's daily liquidity is real; its return is set by the public market for the listed BDCs and closed-end funds it holds.
HALX sells SpaceX to keep its AI hedge honest
A five-for-five rebalance trades a record-IPO holding for industrial ballast, giving up the name some shareholders bought the fund to own.
QGRO's reset sold Nvidia and made Lockheed Martin a 3.5% bet
American Century's quality screen dropped Nvidia and handed Lockheed Martin its largest sleeve increase, a move that says more about the rulebook than the market.
THNR's rebalance moved the trade to the trial money
Gilead and Structure Therapeutics enter a 20-stock index, while a $5.8 million fund's return still rides on Eli Lilly.
VFLO's 25-name growth cut is the real screen
The September 18 rebalance replaced five familiar names with mature technology, media and industrial franchises, making the growth filter the part of the index that does the real work.
OUSM's quality screen just made its biggest bet a sector call
A 111-name portfolio whose sector line binds harder than its single-name cap keeps producing sector outcomes under a quality label.
Europe's ETF flows chased the tape, and the tape was defensive
European ETF flows tracked last week's defensive tape, reversing the split this publication has been documenting since August.
GCSH's raise says the front-end trade grew a credit leg
Three months, $263 million, and a Fed hike that extends the front-end parking trade instead of closing it.
Nuveen's 0.37% bond ETF bets on the index's blind spots
An active bond fund charging 0.37% against the Agg is a wager that the index's blind spots are worth the fee.
A tripling call for bitcoin ETFs rests on allocators, not wrappers
Bitcoin funds sit just below gold's asset base, but tripling that depends on institutions that have barely started allocating.
WisdomTree's inflation bundle runs on a 28% energy bet
A commodities-and-TIPS wrapper answers real dispersion between the two—right up until the commodity leg's energy weight is the only thing producing the return.
Direxion's ORCU turns Oracle's growth-versus-severance churn into a daily trade
A 2x daily reset makes the AI build-out debate a one-day trade, with a restructuring budget still climbing as the source of movement.
The ETF record belongs to three funds, not the shelf
Record inflows keep landing in three cheap funds, while BNY's $20 billion book, Amplify's 15% private sleeve and a 1,100-point value gap add shelf space that moves none of the dollars.
The AI-power trade is now a private deal
Brookfield's $600 million ACME tie-up and a day of clean-energy procurement should worry the issuers who just listed data-center funds with no assets.
State Street extends proxy voting choice to its ACWI UCITS ETF
Handing the vote back costs almost nothing on an index fund; the test is whether it extends to strategies where the manager's vote can run against the benchmark.
Breadth widened, and 67% of large-cap funds still lost
The mid-year SPIVA card prices the broadening-out thesis at twelve points of hit rate and no majority, which makes it an argument about wrapper pricing rather than stock picking.
Three funds are carrying the ETF industry's record year
The $2 trillion forecast for 2026 is Q4 seasonality applied to this year's run rate; underneath the record, the money keeps routing to the same few tickers.
BNY's $20 billion ETF suite is mostly free beta
The milestone measures distribution, not revenue — and the five-fund mix shows where BNY's ETF business actually has to earn.
The value label hides three rule books and a 1,100-point gap
Three funds file as value, follow different index rules, and finished the year 1,100 basis points apart—the cost of screening on a category instead of a methodology.
Amplify's sports ETF sells fandom; the private sleeve is the test
The filing's 15% private allocation is what a daily-priced wrapper cannot cleanly value—and where the product will be judged.
The SEC's clock, not demand, decides the next ETF wave
With the SEC's comment period closed, the 60- and 75-day effectiveness windows set the launch order for novel ETF filings.
Fidelity International adds a US growth sleeve to its active ETF range
The cheapest product a large issuer can build still has to win finite shelf space, and Fidelity's new US growth fund has not disclosed the fee that would decide it.
Texas Stock Exchange opens with the two easiest listings it could pick
A closing bell in Dallas confirms a new US primary-listing venue works on paper; the harder question is whether it can carry the funds the industry is straining to quote.